Gut dysbiosis: a potential link between increased cancer risk in ageing and inflammaging

The Lancet Oncology

Volumn 19, Issue 6, 2018, Pages e295-e304

  Biragyn, Arya ^a   Ferrucci, Luigi ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; SHORT CHAIN FATTY ACID; AUTACOID;

AGING; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CELL AGING; CELL MUTANT; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; DISEASE MODEL; DYSBIOSIS; FRAIL ELDERLY; HUMAN; IMMUNE SYSTEM; IMMUNOPATHOLOGY; INFECTIOUS AGENT; INFLAMMATION; INTESTINE FLORA; NONHUMAN; PRIORITY JOURNAL; REJUVENATION; REVIEW; AGE; AGED; ANIMAL; FEMALE; HOST PATHOGEN INTERACTION; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; INCIDENCE; INTESTINE; MALE; MICROBIOLOGY; NEOPLASM; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ANIMALS; DYSBIOSIS; FEMALE; FRAIL ELDERLY; GASTROINTESTINAL MICROBIOME; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOCOMPROMISED HOST; INCIDENCE; INFLAMMATION; INFLAMMATION MEDIATORS; INTESTINES; MALE; NEOPLASMS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 85047735448     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(18)30095-0     Document Type: Review

References (82)

1. Smith, BD, Smith, GL, Hurria, A, Hortobagyi, GN, Buchholz, TA, Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 27 (2009), 2758–2765.
2. Bluethmann, SM, Mariotto, AB, Rowland, JH, Anticipating the “Silver Tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomarkers Prev 25 (2016), 1029–1036.
3. US Census Bureau. Population projections of the United States by age, sex, race, and hispanic origin: 1995 to 2050. https://www.census.gov/prod/1/pop/p25-1130/p251130.pdf, 1996. (Accessed 1 December 2017)
4. Tomasetti, C, Li, L, Vogelstein, B, Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention. Science 355 (2017), 1330–1334.
5. Kang, TW, Yevsa, T, Woller, N, et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479 (2011), 547–551.
6. Van Allen, EM, Miao, D, Schilling, B, et al. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science 350 (2015), 207–211.
7. Burnet, M, Cancer—a biological approach. I. The processes of control. BMJ 1 (1957), 779–786.
8. Schreiber, RD, Old, LJ, Smyth, MJ, Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 331 (2011), 1565–1570.
9. Sebastiani, P, Thyagarajan, B, Sun, F, et al. Biomarker signatures of aging. Aging Cell 16 (2017), 329–338.
10. Biagi, E, Nylund, L, Candela, M, et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One, 5, 2010, e10667.
11. Jeffery, IB, Lynch, DB, O'Toole, PW, Composition and temporal stability of the gut microbiota in older persons. ISME J 10 (2016), 170–182.
12. Cullender, TC, Chassaing, B, Janzon, A, et al. Innate and adaptive immunity interact to quench microbiome flagellar motility in the gut. Cell Host Microbe 14 (2013), 571–581.
13. Hearps, AC, Martin, GE, Angelovich, TA, et al. Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function. Aging Cell 11 (2012), 867–875.
14. Bouchlaka, MN, Sckisel, GD, Chen, M, et al. Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy. J Exp Med 210 (2013), 2223–2237.
15. Routy, B, Le Chatelier, E, Derosa, L, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science, 2018 published online Jan 5. DOI:10.1126/science.aan3706.
16. Gopalakrishnan, V, Spencer, CN, Nezi, L, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science, 2018 published online Jan 5. DOI:10.1126/science.aan4236.
17. Coussens, LM, Werb, Z, Inflammation and cancer. Nature 420 (2002), 860–887.
18. Crusz, SM, Balkwill, FR, Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol 12 (2015), 584–596.
19. Round, JL, Mazmanian, SK, The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9 (2009), 313–323.
20. Atarashi, K, Tanoue, T, Oshima, K, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500 (2013), 232–236.
21. Macia, L, Tan, J, Vieira, AT, et al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat Commun, 6, 2015, 6734.
22. Nastasi, C, Candela, M, Bonefeld, CM, et al. The effect of short-chain fatty acids on human monocyte-derived dendritic cells. Sci Rep, 5, 2015, 16148.
23. Byndloss, MX, Olsan, EE, Rivera-Chavez, F, et al. Microbiota-activated PPAR-gamma signaling inhibits dysbiotic Enterobacteriaceae expansion. Science 357 (2017), 570–575.
24. Kelly, CJ, Zheng, L, Campbell, EL, et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe 17 (2015), 662–671.
25. Chang, PV, Hao, LM, Offermanns, S, Medzhitov, R, The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA 111 (2014), 2247–2252.
26. Furusawa, Y, Obata, Y, Fukuda, S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504 (2013), 446–450.
27. Lukovac, S, Belzer, C, Pellis, L, et al. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids. MBio 5 (2014), e01438–e01514.
28. Sokol, H, Pigneur, B, Watterlot, L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 105 (2008), 16731–16736.
29. Plovier, H, Everard, A, Druart, C, et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med, 23, 2017, 107.
30. Matsumoto, M, Kurihara, S, Kibe, R, Ashida, H, Benno, Y, Longevity in mice is promoted by probiotic-induced suppression of colonic senescence dependent on upregulation of gut bacterial polyamine production. PLoS One, 6, 2011, e23652.
31. Hu, B, Elinav, E, Huber, S, et al. Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. Proc Natl Acad Sci USA 110 (2013), 9862–9867.
32. O'Toole, P, Jeffery, IB, Gut bicrobota and aging. Science 305 (2015), 1214–1215.
33. Kong, F, Hua, Y, Zeng, B, Ning, R, Li, Y, Zhao, J, Gut microbiota signatures of longevity. Curr Biol 26 (2016), R832–R833.
34. Claesson, MJ, Jeffery, IB, Conde, S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 488 (2012), 178–184.
35. Rampelli, S, Candela, M, Turroni, S, et al. Functional metagenomic profiling of intestinal microbiome in extreme ageing. Aging (Albany NY) 5 (2013), 902–912.
36. Woodmansey, EJ, McMurdo, ME, Macfarlane, GT, Macfarlane, S, Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotic-treated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol 70 (2004), 6113–6122.
37. Talegawkar, SA, Bandinelli, S, Bandeen-Roche, K, et al. A higher adherence to a Mediterranean-style diet is inversely associated with the development of frailty in community-dwelling elderly men and women. J Nutr 142 (2012), 2161–2166.
38. Berger, NA, Obesity and cancer pathogenesis. Ann NY Acad Sci 1311 (2014), 57–76.
39. Grivennikov, SI, Greten, FR, Karin, M, Immunity, inflammation, and cancer. Cell 140 (2010), 883–899.
40. Yoshimoto, S, Loo, TM, Atarashi, K, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 499 (2013), 97–101.
41. Ridker, PM, MacFadyen, JG, Thuren, T, et al. Effect of interleukin-1beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet 390 (2017), 1833–1842.
42. Thevaranjan, N, Puchta, A, Schulz, C, et al. Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction. Cell Host Microbe 21 (2017), 455–466.
43. Sacksteder, MR, Occurrence of spontaneous tumors in the germfree F344 rat. J Natl Cancer Inst 57 (1976), 1371–1373.
44. Ferrucci, L, Corsi, A, Lauretani, F, et al. The origins of age-related proinflammatory state. Blood 105 (2005), 2294–2299.
45. Suganuma, M, Okabe, S, Marino, MW, Sakai, A, Sueoka, E, Fujiki, H, Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice. Cancer Res 59 (1999), 4516–4518.
46. Muller-Hermelink, N, Braumuller, H, Pichler, B, et al. TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis. Cancer Cell 13 (2008), 507–518.
47. Henry, CJ, Casas-Selves, M, Kim, J, et al. Aging-associated inflammation promotes selection for adaptive oncogenic events in B cell progenitors. J Clin Invest 125 (2015), 4666–4680.
48. Challen, GA, Boles, NC, Chambers, SM, Goodell, MA, Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-beta1. Cell Stem Cell 6 (2010), 265–278.
49. Baldridge, MT, King, KY, Boles, NC, Weksberg, DC, Goodell, MA, Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature 465 (2010), 793–797.
50. Grizzle, WE, Xu, X, Zhang, S, et al. Age-related increase of tumor susceptibility is associated with myeloid-derived suppressor cell mediated suppression of T cell cytotoxicity in recombinant inbred BXD12 mice. Mech Ageing Dev 128 (2007), 672–680.
51. Gabrilovich, DI, Nagaraj, S, Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9 (2009), 162–174.
52. Hurez, V, Daniel, BJ, Sun, L, et al. Mitigating age-related immune dysfunction heightens the efficacy of tumor immunotherapy in aged mice. Cancer Res 72 (2012), 2089–2099.
53. Sapey, E, Greenwood, H, Walton, G, et al. Phosphoinositide 3-kinase inhibition restores neutrophil accuracy in the elderly: toward targeted treatments for immunosenescence. Blood 123 (2014), 239–248.
54. Tortorella, C, Piazzolla, G, Spaccavento, F, Vella, F, Pace, L, Antonaci, S, Regulatory role of extracellular matrix proteins in neutrophil respiratory burst during aging. Mech Ageing Dev 119 (2000), 69–82.
55. Zhang, D, Chen, G, Manwani, D, et al. Neutrophil ageing is regulated by the microbiome. Nature 525 (2015), 528–532.
56. Demers, M, Wong, SL, Martinod, K, et al. Priming of neutrophils toward NETosis promotes tumor growth. Oncoimmunology, 5, 2016, e1134073.
57. Lood, C, Arve, S, Ledbetter, J, Elkon, KB, TLR7/8 activation in neutrophils impairs immune complex phagocytosis through shedding of FcgRIIA. J Exp Med, 214, 2017, 2103.
58. de Visser, KE, Korets, LV, Coussens, LM, De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7 (2005), 411–423.
59. Rowley, DA, Stach, RM, B lymphocytes secreting IgG linked to latent transforming growth factor-beta prevent primary cytolytic T lymphocyte responses. Int Immunol 10 (1998), 355–363.
60. Ziegler-Heitbrock, L, Ancuta, P, Crowe, S, et al. Nomenclature of monocytes and dendritic cells in blood. Blood 116 (2010), e74–e80.
61. El Khoury, J, Toft, M, Hickman, SE, et al. CCR2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med 13 (2007), 432–438.
62. Qian, BZ, Li, J, Zhang, H, et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475 (2011), 222–225.
63. Hanna, RN, Cekic, C, Sag, D, et al. Patrolling monocytes control tumor metastasis to the lung. Science 350 (2015), 985–990.
64. Zawada, AM, Rogacev, KS, Rotter, B, et al. SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood 118 (2011), e50–e61.
65. Puchta, A, Naidoo, A, Verschoor, CP, et al. TNF drives monocyte dysfunction with age and results in impaired anti-pneumococcal immunity. PLoS Pathog, 12, 2016, e1005368.
66. Delneste, Y, Charbonnier, P, Herbault, N, et al. Interferon-gamma switches monocyte differentiation from dendritic cells to macrophages. Blood 101 (2003), 143–150.
67. Della Bella, S, Bierti, L, Presicce, P, et al. Peripheral blood dendritic cells and monocytes are differently regulated in the elderly. Clin Immunol 122 (2007), 220–228.
68. Jing, Y, Shaheen, E, Drake, RR, Chen, N, Gravenstein, S, Deng, Y, Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood. Hum Immunol 70 (2009), 777–784.
69. Munn, DH, Mellor, AL, IDO and tolerance to tumors. Trends Mol Med 10 (2004), 15–18.
70. Okabe, Y, Medzhitov, R, Tissue-specific signals control reversible program of localization and functional polarization of macrophages. Cell 157 (2014), 832–844.
71. hi monocyte precursors. Mucosal Immunol 6 (2013), 498–510.
72. Nielsen, SR, Quaranta, V, Linford, A, et al. Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis. Nat Cell Biol 18 (2016), 549–560.
73. Dagvadorj, J, Shimada, K, Chen, S, et al. Lipopolysaccharide induces alveolar macrophage necrosis via CD14 and the P2X7 receptor leading to interleukin-1alpha release. Immunity 42 (2015), 640–653.
74. Zhong, Z, Umemura, A, Sanchez-Lopez, E, et al. NF-kappaB restricts inflammasome activation via elimination of damaged mitochondria. Cell 164 (2016), 896–910.
75. Xue, W, Zender, L, Miething, C, et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445 (2007), 656–660.
76. Braumuller, H, Wieder, T, Brenner, E, et al. T-helper-1-cell cytokines drive cancer into senescence. Nature 494 (2013), 361–365.
77. Vetizou, M, Pitt, JM, Daillere, R, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350 (2015), 1079–1084.
78. Iida, N, Dzutsev, A, Stewart, CA, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 342 (2013), 967–970.
79. Sivan, A, Corrales, L, Hubert, N, et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350 (2015), 1084–1089.
80. Denduluri, N, Ershler, WB, Aging biology and cancer. Semin Oncol 31 (2004), 137–148.
81. Handelsman, Y, Leroith, D, Bloomgarden, ZT, et al. Diabetes and cancer—an AACE/ACE consensus statement. Endocr Pract 19 (2013), 675–693.
82. Lee-Chang, C, Bodogai, M, Moritoh, K, et al. Aging converts innate B1a cells into potent CD8+ T cell inducers. J Immunol 196 (2016), 3385–3397.